Back to Superinvestors
SUPERINVESTOR HOLDERS
GSK
GlaxoSmithKline PLC ADR
Healthcare · Drug Manufacturers - General
- Holders
- 9
- Total value
- $3,958,763,823
- Total shares
- 75,520,080
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Dodge & Cox
Dodge & Cox
|
48,197,514 | $2,526,513,684 | 1.32% | REDUCE -10,465,460 | 30 Jun 2026 |
|
PRIMECAP Management
PRIMECAP Management Co
|
25,182,068 | $1,320,044,006 | 0.78% | REDUCE -22,470 | 30 Jun 2026 |
|
Charles Brandes
Brandes Investment Partners, LP
|
1,483,198 | $77,750,479 | 0.55% | ADD +30,196 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
346,157 | $18,145,561 | 0.01% | ADD +63,034 | 30 Jun 2026 |
|
Thomas Kahn
Kahn Brothers Group
|
158,438 | $8,305,319 | 1.31% | REDUCE -2,544 | 30 Jun 2026 |
|
Tweedy, Browne
Tweedy, Browne Company
|
81,527 | $4,273,645 | 0.32% | REDUCE -258 | 30 Jun 2026 |
|
Richard Pzena
Pzena Investment Management
|
24,507 | $1,284,635 | 0.00% | ADD +5,684 | 30 Jun 2026 |
|
Murray Stahl
Horizon Kinetics LLC
|
24,046 | $1,260,491 | 0.01% | REDUCE -373 | 30 Jun 2026 |
|
Hersh Cohen
ClearBridge Investments
|
22,625 | $1,186,003 | 0.00% | ADD +385 | 30 Jun 2026 |